Anti-platelet and anti-coagulant therapy in peripheral arterial disease prior to surgical intervention

A Harky, P Maskell, M Burgess - Vascular, 2019 - journals.sagepub.com
Objective Peripheral artery disease is a major clinical co-morbidity that can significantly
affect quality of life, especially in the presence of diabetes mellitus and older age. The focus …

Effects of successful percutaneous lower extremity revascularization on cardiovascular outcome in patients with peripheral arterial disease

G Giugliano, L Di Serafino, C Perrino, V Schiano… - International journal of …, 2013 - Elsevier
Background Lower extremity peripheral arterial disease (LE-PAD) reduces walking capacity
and is associated with an increased cardiovascular risk. Endovascular revascularization of …

[HTML][HTML] The prospective GermanVasc cohort study

A Kotov, F Peters, ES Debus, T Zeller, P Heider… - Vasa, 2021 - econtent.hogrefe.com
Background: Previous observational studies reported a wide variation and possible room for
improvement in the treatment of patients suffering from symptomatic peripheral artery …

Perceptions of Canadian vascular surgeons toward pharmacologic risk reduction in patients with peripheral artery disease: 2018 update

B Li, K Salata, C de Mestral, MA Hussain… - Annals of Vascular …, 2019 - Elsevier
Background Vascular surgeons have a central role in managing peripheral artery disease
(PAD). This study assessed their knowledge, attitudes, and behaviors regarding …

World regional differences in outcomes for patients with peripheral artery disease: Insights from the EUCLID trial

L Norgren, R North, I Baumgartner… - Vascular …, 2022 - journals.sagepub.com
Regional variations exist in the epidemiology of peripheral artery disease (PAD), in
comorbidities, use of secondary prevention, and outcomes. Large studies of these variations …

Incidence and factors associated with major amputation in patients with peripheral artery disease: insights from the EUCLID trial

CA Long, H Mulder, FGR Fowkes… - … Quality and Outcomes, 2020 - Am Heart Assoc
Background: Peripheral artery disease (PAD) is associated with increased risk of mortality,
cardiovascular morbidity, and major amputation. Data on major amputation from a large …

[HTML][HTML] Increased long-term bleeding complications in females undergoing endovascular revascularization for peripheral arterial disease

K Marulanda, E Duchesneau, S Patel… - Journal of vascular …, 2022 - Elsevier
Objective Females with peripheral arterial disease (PAD) treated with endovascular
interventions have increased limb-based procedural complications compared with males …

Contemporary review of antithrombotic therapy in peripheral artery disease

CN Hess, MP Bonaca - Circulation: Cardiovascular Interventions, 2020 - Am Heart Assoc
Patients with peripheral artery disease (PAD) are at heightened risk for ischemic events
related to atherothrombosis. Antithrombotic therapies can reduce the risk of …

[HTML][HTML] Vascular diagnostic and surgical treatments before lower limb amputations in patients with arterial vascular diseases: a population based study from 2013 to …

K Hagenström, C Garbe, ES Debus… - European Journal of …, 2021 - Elsevier
Objective Patients with peripheral artery disease (PAD) have an increased risk of lower limb
amputation. Given the international wide variance in major amputations, the high mortality …

[HTML][HTML] Ten year mortality in different peripheral arterial disease stages: a population based observational study on outcome

F Sartipy, B Sigvant, F Lundin, E Wahlberg - European Journal of Vascular …, 2018 - Elsevier
Objective The aim was to determine long-term mortality rates and the underlying cause of
death for subjects with different peripheral arterial disease (PAD) stages in a population …